Oppenheimer & CO Inc CELLDEX THERAPEUTICS INC NEW Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 24, 2019
SELL
N/A
-16,735 Closed
0 $0
Q4 2018

Jan 29, 2019
SELL
N/A
-6,000 Reduced 26.39%
16,735 $3,000
Q3 2018

Oct 26, 2018
SELL
N/A
-13,200 Reduced 36.73%
22,735 $11,000
Q2 2018

Aug 10, 2018
SELL
N/A
-29,335 Reduced 44.94%
35,935 $19,000
Q1 2018

May 01, 2018
SELL
N/A
-600 Reduced 0.91%
65,270 $152,000
Q4 2017

Feb 07, 2018
BUY
N/A
5,875 Added 9.79%
65,870 $188,000
Q3 2017

Nov 09, 2017
BUY
N/A
59,995
59,995 $172,000
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email